FullHope Biomedical Co.,Ltd. (TPEX:7773)

Market Cap	1.18B -21.2%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	39.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	201
Open	29.50
Previous Close	29.30
Day's Range	29.50 - 29.50
52-Week Range	19.90 - 38.35
Beta	1.04
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About FullHope Biomedical

FullHope Biomedical Co.,Ltd. engages in the research and development of immune system-related services. It develops FHCT001 and FHCT003, an immune cell therapies for cancer; and FHCT002, an auto-immune cell therapy, as well as diagnostic tools. The company also provides various services, including immunoprofiling, circulating tumor cells testing, regulation of cell therapy, contracting immune cell manufacturing, immune cell bank, contract research organization, and endotoxin and mycoplasma detection. FullHope Biomedical Co.,Ltd. was founded in ...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7773

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error